AAVs in Retinal Gene Therapy
Type
Blog Post
Published
July 31, 2018, 12:55 p.m.
...integration into the genome, and its large DNA packaging capacity is well suited for larger transgenes....humans, and its low immunogenicity is critical when systemic delivery of high doses of vectors are needed. ...this gene can be targeted to RPE cells using a lentiviral vector and a clinical trial is ongoing.
Moving...vectors (AAVs) to treat an inherited retinal degenerative disease called Retinitis Pigmentosa. I quickly...other viral vectors such as adenovirus (AdV) and lentivirus (LV) are known to transduce retinal cells, AAV...pigmentosa, achromatopsia, and age-related macular degeneration are ongoing and some will hopefully follow in...muscular dystrophy, spinal muscular atrophy, neurodegenerative diseases and metabolic diseases are also underway...